News item
PBAC to assess tougher GLP-1 prescribing restrictions
As PBS prescriptions surge, it will review whether the 2024 authority change has been effective in limiting GLP-1 use to its recommended population.
This is for Doceo members
Membership is free. Join in a minute, or log in if you’re already a member.